You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

uveal melanoma

Showing 2501 - 2525 of 2,548
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Unresectable Metatstatic Cutaneous Melanoma Trial in France, Germany, Switzerland (852A)

Completed
  • Melanoma
  • Unresectable Metatstatic Cutaneous Melanoma
  • Lyon, France
  • +7 more
Oct 24, 2008

Melanoma Trial in Lebanon, Oklahoma City (852A)

Completed
  • Melanoma
  • Lebanon, New Hampshire
  • +1 more
Oct 24, 2008

Stage IV Melanoma, Stage III Melanoma, Recurrent Melanoma Trial in United States (allovectin-7, allovectin-7/dacarbazine,

Completed
  • Stage IV Melanoma
  • +2 more
  • Little Rock, Arkansas
  • +43 more
Jul 23, 2008

Malignant Melanoma Trial in Copenhagen (ultrasound contrast)

Completed
  • Malignant Melanoma
  • ultrasound contrast
  • Copenhagen, Denmark
    Copenhagen univercity hospital, Department of Radiology, section
Jun 17, 2008

Melanoma, Metastases Trial in United States (M200 (volociximab) in Combination with Dacarbazine (DTIC))

Completed
  • Melanoma
  • Metastases
  • M200 (volociximab) in Combination with Dacarbazine (DTIC)
  • Birmingham, Alabama
  • +6 more
Aug 2, 2008

Immunotherapy Trial in Nantes (autologous Melan-A/MART-1 specific CTL clones)

Completed
  • Immunotherapy
  • autologous Melan-A/MART-1 specific CTL clones
  • Nantes, Pays de la Loire, France
    Nantes University Hopspital
Jul 22, 2008

Organ Transplants Trial in Copenhagen (Photodynamic Therapy)

Unknown status
  • Organ Transplants
  • Photodynamic Therapy
  • Copenhagen, Copenhagen NV, Denmark
    Bispebjerg Hospital
May 30, 2008

Malignant Melanoma, Tumor Metastasis Trial in Houston (investigational drug INGN 241)

Unknown status
  • Malignant Melanoma
  • Neoplasm Metastasis
  • investigational drug INGN 241
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 28, 2008

Melanoma, Tumor Metastasis Trial run by the NCI (Immunodominant peptides from three melanoma antigens, MART-1, GP100 and

Completed
  • Melanoma
  • Neoplasm Metastasis
  • Immunodominant peptides from three melanoma antigens, MART-1, GP100 and tyrosinase
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma Trial run by the NCI (gp100 human melanoma peptide)

Completed
  • Melanoma
  • gp100 human melanoma peptide
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma Trial in Philadelphia (Sub-Tenon triamcinolone 40mg)

Completed
  • Melanoma
  • Sub-Tenon triamcinolone 40mg
  • Philadelphia, Pennsylvania
    Ocular Oncology Service, Wills Eye Institute
Feb 28, 2007

Melanoma, Tumor Metastasis Trial run by the NCI (GP100 peptide, IL-2)

Completed
  • Melanoma
  • Neoplasm Metastasis
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma, Malignant Metastatic Melanoma Trial in United States (MEDI--522, Integrin + Dacarbazine)

Completed
  • Melanoma
  • Malignant Metastatic Melanoma
  • MEDI--522
  • Integrin + Dacarbazine
  • Scottsdale, Arizona
  • +24 more
Jan 14, 2008

Peritoneal Tumors, Stomach Tumors Trial run by the NCI (CHPP with cisplatin)

Completed
  • Peritoneal Neoplasms
  • Stomach Neoplasms
  • CHPP with cisplatin
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma Inhibitory Activity: A Serological Marker for

Unknown status
  • Melanoma
  • +2 more
  • Treatment of metastatic disease
  • Munich, Germany
    Dept of Ophthalmology, University of Munich
Dec 5, 2006

Melanoma, Sarcoma Trial run by the NCI (double isolated limb perfusion with melphalan alone)

Completed
  • Melanoma
  • Sarcoma
  • double isolated limb perfusion with melphalan alone
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma Trial run by the NCI (melphalan, tumor necrosis factor, interferon-gamma)

Completed
  • Melanoma
  • Bethesda, Maryland
    National Cancer Institute (NCI)
Mar 3, 2008

Melanoma Trial in Rome (Melan-A, Melan-A plus Dacarbazine)

Completed
  • Melanoma
  • Melan-A
  • Melan-A plus Dacarbazine
  • Rome, Italy
  • +1 more
Nov 15, 2007

Melanoma Trial in United States (ATN-224, Temozolomide)

Unknown status
  • Melanoma
  • Tucson, Arizona
  • +16 more
Dec 4, 2007

MicroRNA Expression and Function in Cutaneous Malignant Melanoma

Completed
  • Melanoma
    • Copenhagen, Denmark
      Rigshospitalet
    Sep 26, 2007

    Malignant Melanoma Trial in Lausanne (CYT004-MelQbG10)

    Completed
    • Malignant Melanoma
    • CYT004-MelQbG10
    • Lausanne, Vaude, Switzerland
      Centre Pluridisciplinaire d'Oncologie & LICR, CHUV
    Sep 19, 2007

    Melanoma Trial in Berlin (CYT004-MelQbG10)

    Completed
    • Melanoma
    • CYT004-MelQbG10
    • Berlin, Germany
      Dept. of Dermatology, Venerology and Allergy
    Sep 19, 2007

    Ocular Melanoma Trial in Berlin (Gemcitabine, Treosulfan)

    Unknown status
    • Ocular Melanoma
    • Berlin, Germany
      Hematology & Oncology Charité CBF Berlin
    Aug 30, 2007

    Melanoma Trial in North Sydney, Waratah (PV-10 (rose bengal disodium, 10%))

    Completed
    • Melanoma
    • PV-10 (rose bengal disodium, 10%)
    • North Sydney, New South Wales, Australia
    • +1 more
    Aug 22, 2007

    Melanoma Trial in Buenos Aires (DC/Apo-Nec)

    Completed
    • Melanoma
    • DC/Apo-Nec
    • Buenos Aires, Capital Federal, Argentina
      Instituto Médico Alexander Fleming
    Aug 10, 2007